SCHEMBL10086341

SCHEMBL10086341

Nc1c(Oc2ccc3ccc(Oc4cc(O)c5c(c4N)C(=O)c4ccccc4C5=O)cc3c2)cc(O)c2c1C(=O)c1ccccc1C2=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.47
MAPT P10636 7/20 0.44
MEN1 O00255 6/20 0.44
KMT2A Q03164 6/20 0.44
TDP1 Q9NUW8 5/20 0.44
MAPK1 P28482 3/20 0.44
HPGD P15428 2/20 0.44
RECQL P46063 2/20 0.44
MAOA P21397 2/20 0.44
ALDH1A1 P00352 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
KDM4E B2RXH2 2/20 0.44
DAPK1 P53355 2/20 0.44
TTR P02766 2/20 0.44
CYP1A1 P04798 1/20 0.44
CYP3A4 P08684 1/20 0.44
HSPD1 P10809 1/20 0.44
ALOX15 P16050 1/20 0.44
ALOX12 P18054 1/20 0.44
ACHE P22303 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17342967 0.97 ADORA2A (0.47) ADORA2AMAPTMEN1KMT2ATDP1
SCHEMBL10085298 0.97 ADORA2A (0.49) ADORA2AMAPTMEN1KMT2ATDP1
SCHEMBL9154959 0.86 ADORA2A (0.52) ADORA2AMAPTMEN1KMT2ATDP1
SCHEMBL10812235 0.86 ADORA2A (0.52) ADORA2AMAPTMEN1KMT2ATDP1
SCHEMBL10086463 0.86 ADORA2A (0.52) ADORA2AMAPTMEN1KMT2ATDP1
SCHEMBL92475 0.86 ADORA2A (0.62) ADORA2AMAPTMEN1KMT2ATDP1
SCHEMBL9386255 0.85 ADORA2A (0.48) ADORA2AMAPTMEN1KMT2ATDP1
SCHEMBL14319681 0.84 ADORA2A (0.50) ADORA2AMAPTMEN1KMT2ATDP1
SCHEMBL8731564 0.84 ADORA2A (0.50) ADORA2AMAPTMEN1KMT2ATDP1
SCHEMBL10809923 0.84 ADORA2A (0.50) ADORA2AMAPTMEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2039728-B1 Red paint mixture LANXESS DEUTSCHLAND GMBH (DE) 2012-05-02 EP disclosed
EP-2039728-A2 Red paint mixture Lanxess Deutschland GmbH (DE) 2009-03-25 EP disclosed
US-20090076199-A1 RED DYE MIXTURE LANXESS DEUTSCHLAND GMBH (DE) 2009-03-19 US disclosed
US-20090076199-A1 RED DYE MIXTURE LANXESS DEUTSCHLAND GMBH (DE) 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076199-A1 RED DYE MIXTURE LDHA, IK, LDHB ADORA2A 4777/4885MAPT 802/4885MEN1 2206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.